US President Donald Trump's economic policies have stopped pharmaceutical and biotech companies from going ahead with major ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

"We are pleased to welcome Dalia to the company in advance of the upcoming readout for our Phase 3 EFZO-FIT™ study of ...

The Rice Biotech Launch Pad and RBL LLC will hold an event to celebrate the official launch and lab opening of RBL LLC on May 5, following a Rice University presidential lecture on the significance of ...

A redistribution of power no one is ready for For centuries, gender has dictated roles, opportunities, and power. It has ...

Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...

A bankruptcy filing Sunday by 23andMe, a genetic testing and biotechnology company, is shining light on what could happen to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...